Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Baricitinib was effective in treating both early and late onset alopecia areata.

ARTS helps stop tumors by promoting cell death.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Combining finasteride and terazosin can cause severe allergic reactions.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

5α-Reductase inhibitors don't cause depression.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

The new compound may be a safer alternative to finasteride for prostate protection.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

A new compound may treat benign prostatic hyperplasia better than finasteride.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.